Articles tagged with “pharma-r-d”

Learn how the Pistoia Alliance is developing Agentic AI standards, communication protocols, and validation frameworks for secure pharmaceutical R&D workflows.

Analyze how agentic AI is integrated into pharma R&D through the Sanofi-Owkin partnership, and examine the build-vs-partner drug development framework.

Analyze the integration of agentic AI systems in pharmaceutical R&D, examining Incyte's adoption of the Kosmos AI Scientist for automated drug discovery.

An in-depth analysis of Isomorphic Labs' $2.1B Series B funding. Examine the IsoDDE AI drug design engine, AlphaFold's role, and biotech industry impacts.

Analyze OpenAI's GPT-Rosalind, a biochemical reasoning model for life sciences. Learn how Amgen, Moderna, and Thermo Fisher apply this AI to drug discovery.

Learn how AI, LLMs, and agentic AI can build a "Second Brain" for pharma R&D. Updated for 2026 with GraphRAG benchmarks, FDA AI guidance, and enterprise deployment patterns for searchable institutional memory in drug discovery.

Learn about Causaly Pipeline Graph and Agentic Research, AI platforms integrating competitive intelligence and knowledge graphs for pharma R&D. Updated April 2026 with market data, FDA guidance, and platform evolution.

Learn what a Contract Research Organization (CRO) is and its critical role in modern drug development. Updated for 2026 with latest market data, ICH E6(R3) guidelines, BIOSECURE Act impacts, AI adoption trends, and major M&A activity including Thermo Fisher/Clario and Syneos Health privatization.